Combined oral contraceptives and thromboembolism

CPMP PUBLIC ASSESSMENT REPORT Combined oral contraceptives and venous thromboembolism

Oral contraceptives, ABO blood types and thromboembolism.

Oral contraceptives, venous thromboembolism, and the courts.

http://bmj.com/cgi/content/full/325/7363/504 Updated information and services can be found at: These include: References http://bmj.com/cgi/content/full/325/7363/504#BIBL This article cites 8 articles, 6 of which can be accessed free at: Rapid responses http://bmj.com/cgi/eletter-submit/325/7363/504 You can respond to this article at: http://bmj.com/cgi/content/full/325/7363/504#responses free ...

Risk of venous thromboembolism with oral contraceptives.

E1278 CMAJ, December 13, 2011, 183(18) © 2011 Canadian Medical Association or its licensors The lifetime incidence of venous thromboembolism for both men and women is estimated at 1 per 1000. Increasing our understanding of the precipitating risk factors, as well as optimizing the prevention of this condition in high-risk populations, could help to reduce the burden of venous thromboembolism. A...

Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism.

We wish to comment on the Dinger and Shapiro commentary article published in the January 2012 issue of this Journal.1 Following the publication of papers regarding the risk of venous thromboembolism (VTE) with combined oral contraceptives (COCs) we would like to share some information regarding comparison between drospirenonecontaining COCs and other COCs in Croatia. This short study was conduc...